...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International ophthalmology >Laser in situ keratomileusis application for myopia over minus 14 diopter with long-term follow-up
【24h】

Laser in situ keratomileusis application for myopia over minus 14 diopter with long-term follow-up

机译：屈光度数为14屈光度数的近视眼激光原位角膜磨镶术的长期随访

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To evaluate the results of laser in situ keratomileusis (LASIK) for extremely high myopia with a minimum follow-up of 10 years. Istanbul Surgery Hospital, Istanbul, Turkey. Extremely high myopic patients treated with LASIK between 1995 and 1997 with a minimum follow-up of 10 years are reviewed retrospectively. Cases over 14 diopters (D) of myopia were included in the study. From 143 eyes with high myopia greater than -14 D operated on between 1995 and 1997, 39 eyes (26 patients) were available for 10-year follow-up. RESULTS: The manifest average spherical equivalent refraction was -21.7 ± 5.8 D prior to surgery. This value became -6.0 ± 3.3 D after at least 10 years of follow-up. The regression was -6.1 ± 2.2 D in the period starting from the first month of the follow-up until the last control. The uncorrected visual acuity was 0.07 ± 0.1 at the last follow-up. The mean preoperative best-corrected visual acuity (BCVA) was 0.22 ± 0.12 and 0.30 ± 0.17 postoperatively (p < 0.001). Loss or gain of one line or more at the BCVA in the last control were 10.3 and 53.8 %, respectively. The safety and efficacy indexes are 1.56 ± 0.95 and 0.29 ± 0.4, respectively. No corneal ectasias were noted at follow-up. Although LASIK gives reliable results with high degrees of myopia, significant regression develops in the long term.
机译：为了评估极高度近视的激光原位角膜磨镶术（LASIK）的结果，至少需要随访10年。伊斯坦布尔手术医院，伊斯坦布尔，土耳其。回顾性分析1995年至1997年间接受LASIK治疗的极高近视患者，至少随访10年。该研究包括近视度数超过14屈光度（D）的病例。在1995年至1997年间手术的143眼高度近视大于-14 D的眼中，有39眼（26例患者）可以进行10年的随访。结果：术前平均球面等效屈光度为-21.7±5.8D。经过至少10年的随访，该值变为-6.0±3.3D。从随访的第一个月到最后一次对照，回归值为-6.1±2.2D。在最后一次随访中，未矫正的视力为0.07±0.1。术前平均最佳矫正视力（BCVA）为0.22±0.12和术后0.30±0.17（p <0.001）。在最后一个对照中，BCVA的一条线或更多条线的损益分别为10.3和53.8％。安全性和有效性指数分别为1.56±0.95和0.29±0.4。随访中未发现角膜扩张。尽管LASIK可在高度近视方面提供可靠的结果，但从长远来看，会出现明显的消退。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号